Contineum Therapeutics (CTNM) Consolidated Net Income (2023 - 2024)
Historic Consolidated Net Income for Contineum Therapeutics (CTNM) over the last 2 years, with Q4 2024 value amounting to -$14.6 million.
- Contineum Therapeutics' Consolidated Net Income fell 8747.59% to -$14.6 million in Q4 2024 from the same period last year, while for Sep 2025 it was -$14.6 million, marking a year-over-year increase of 5892.79%. This contributed to the annual value of -$42.3 million for FY2024, which is 28599.47% down from last year.
- Latest data reveals that Contineum Therapeutics reported Consolidated Net Income of -$14.6 million as of Q4 2024, which was down 8747.59% from -$10.3 million recorded in Q3 2024.
- In the past 5 years, Contineum Therapeutics' Consolidated Net Income registered a high of $41.6 million during Q2 2023, and its lowest value of -$14.6 million during Q4 2024.